temozolomide,capecitabine
Not Tagged
['prodige23', 'rectal', 'colorectal']
#asco2023: update on #prodige23 for #rectal #cancer with 3m of neo folfoxiri with median f/u of 7 yrs validating earlier results for dfs and mfs; no difference in os. #colorectalcancer #cancerresearch #clinicaltrials 
Co-Director/Co-Leader GI Oncology Research; Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations